discovered that GSK3B may play a role in tumor progression by regulating the Wnt/β-catenin pathway and that GSK3B gene variation is associated with tumor location and tumor-node-metastasis (TNM) stage in CRC patients (51). The gene discussed is GSK3B; the disease is neoplasm.